HomeInsightsPE

Marksans Pharma Ltd PE Ratio

Marksans Pharma Ltd PE Ratio

stocks purchased

₹ 3.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

104.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Marksans Pharma Ltd

NSE: MARKSANS

PE

40.3

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Marksans Pharma Ltd is 40.3 as of 23 Nov 9.00 AM .
  • The P/E Ratio of Marksans Pharma Ltd changed from 13.3 on March 2019 to 21.9 on March 2024 . This represents a CAGR of 8.67% over 6 years.
  • The Latest Trading Price of Marksans Pharma Ltd is ₹ 308.55 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Marksans Pharma Ltd

No data available

Company Fundamentals for Marksans Pharma Ltd

No data available

Image

Marksans Pharma Ltd

NSE: MARKSANS

Share Price

₹ 308.55

-0.45 (-0.15%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024308.55
21 Nov 2024309
19 Nov 2024305.85
18 Nov 2024309.3
14 Nov 2024307.35
13 Nov 2024305.55
12 Nov 2024300.35
11 Nov 2024289
08 Nov 2024298.6
07 Nov 2024301.35

SWOT Analysis Of Marksans Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Marksans Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Marksans Pharma Ltd4013,982
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Marksans Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Marksans Pharma Ltd

No data available

* All values are in %

About Marksans Pharma Ltd

  • Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
  • Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
  • The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
  • The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
  • Marksans Pharma Limited (formerly M/s.

Marksans Pharma Ltd News Hub

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

2024-08-21 00:00:00

News

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

Read more

2024-08-20 00:00:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

2024-08-20 00:00:00

News

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

2024-08-20 00:00:00

News

Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr

Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...

Read more

2024-08-14 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Marksans Pharma Ltd

What is the current PE Ratio of Marksans Pharma Ltd?

The Current PE Ratio of Marksans Pharma Ltd is 40.28 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Marksans Pharma Ltd last year?

The PE Ratio of Marksans Pharma Ltd was 11.99 last year, now the PE ratio is 40.28, showing a year-on-year growth of 235.9%.

What does the PE Ratio of Marksans Pharma Ltd indicate about its stock?

The PE Ratio of Marksans Pharma Ltd is 40.28. This ratio indicates that investors are willing to pay 40.28 times the earnings per share for each share of Marksans Pharma Ltd.

What is the PE Ratio Growth of Marksans Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Marksans Pharma Ltd grew by 235.9% whereas, the EPS ratio grew by 8.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*